The PHiD-CV safety and reactogenicity profile was similar in all groups. reduced HIV+ children: for each vaccine-serotype, percentages of children with opsonophagocytic activity (OPA) titres 8 were 72%, 81%, and 79% for HIV+, HEU, and HUU children. Post-booster, 87% of children in each group experienced OPA titres 8. Reactogenicity was […]